Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Oncology
Renal-Cell Carcinoma
,
Oncology
Quality of Life Drives Patient Preference for Metastatic RCC Drug
Wayne Kuznar
Read More
Lung Cancer
,
Oncology
Afatinib Boosts PFS in EGFR Mutation–Positive Lung Cancer
Wayne Kuznar
Read More
Breast Cancer
,
Oncology
Novel T-DM1 Prolongs Remission in Metastatic Breast Cancer: A New “Smart Bomb”
Audrey Andrews
Read More
Leukemia
,
Oncology
Bosutinib Shows Superior Results in CML
Neil Canavan
,
Neil Canavan
Read More
Leukemia
,
Oncology
Novel Oral B-Cell Receptor Inhibitor Very Effective in Chronic Lymphocytic Leukemia
Caroline Helwick
,
Caroline Helwick
,
Caroline Helwick
Read More
Multiple Myeloma
,
Multiple Myeloma
,
Oncology
VISTA Final Analysis Upholds Survival Benefit of Bortezomib at 5 Years
Caroline Helwick
,
Caroline Helwick
Read More
Multiple Myeloma
,
Multiple Myeloma
,
Oncology
Maintenance Strategies in Elderly Patients with Myeloma Not Eligible for Transplant
Caroline Helwick
,
Caroline Helwick
Read More
Leukemia
,
Oncology
Obinutuzumab Could Give Rituximab a Run for Its Money in Relapsed Indolent NHL
Read More
Leukemia
,
Oncology
Maintenance Rituximab May Be Unnecessary in FL
Caroline Helwick
,
Caroline Helwick
Read More
Multiple Myeloma
,
Multiple Myeloma
,
Oncology
Monoclonal Antibody Elotuzumab Promising in Multiple Myeloma
Read More
22
23
24
25
26
27
Page 25 of 27
Results 241 - 250 of 262